工银新经济人民币(005699)
动态评分： 3.85分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2024-12-31 | CNE0000014W7 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 买入 | 317.81 | 6.29% |
| 2024-12-31 | KYG1146Y1017 | BeiGene Ltd | 买入 | 196.88 | 3.89% |
| 2024-12-31 | KYG0146B1032 | Akeso Inc | 买入 | 187.66 | 3.71% |
| 2024-12-31 | CNE100006KG8 | Chongqing Genrix Biopharmaceutical Co Ltd | 买入 | 173.03 | 3.42% |
| 2024-12-31 | CNE1000048G6 | Remegen Co Ltd | 买入 | 162.71 | 3.22% |
| 2024-12-31 | CNE100003FF7 | Shanghai Junshi Biosciences Co Ltd | 买入 | 154.16 | 3.05% |
| 2024-12-31 | KYG549581067 | Hansoh Pharmaceutical Group Co Ltd | 买入 | 147.59 | 2.92% |
| 2024-12-31 | KYG4818G1010 | Innovent Biologics Inc | 买入 | 145.95 | 2.89% |
| 2024-12-31 | KYG8875G1029 | 3SBio Inc | 买入 | 145.63 | 2.88% |
| 2024-12-31 | CNE1000062J1 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 买入 | 141.34 | 2.8% |
| 2024-12-31 | KYG4672N1198 | HUTCHMED China Ltd | 买入 | 110.26 | 2.18% |
| 2024-12-31 | KYG5252B1023 | Keymed Biosciences Inc | 买入 | 87.76 | 1.74% |
| 2024-12-31 | KYG4783B1032 | InnoCare Pharma Ltd | 买入 | 73.88 | 1.46% |
| 2024-12-31 | CNE100005XJ7 | Shanghai Allist Pharmaceuticals Co Ltd | 买入 | 73.48 | 1.45% |
| 2024-12-31 | CNE100002DD9 | Betta Pharmaceuticals Co Ltd | 买入 | 69.25 | 1.37% |
| 2024-12-31 | CNE100003PR1 | BrightGene Bio-Medical Technology Co Ltd | 买入 | 60.74 | 1.2% |
| 2024-12-31 | HK0000658531 | Simcere Pharmaceutical Group Ltd | 买入 | 59.51 | 1.18% |
| 2024-12-31 | CNE1000026S7 | Luoxin Pharmaceuticals Group Stock Co Ltd | 买入 | 39.19 | 0.78% |
| 2024-12-31 | KYG3825B1059 | Genscript Biotech Corp | 买入 | 34.65 | 0.69% |
| 2024-12-31 | KYG5140J1013 | Jinxin Fertility Group Ltd | 买入 | 34.23 | 0.68% |
公告&资料
